|
|
???tair.name??? >
???browser.page.title.author???
|
"_"???jsp.browse.items-by-author.description???
Showing items 836-845 of 4992 (500 Page(s) Totally)
<< < 79 80 81 82 83 84 85 86 87 88 > >>
View [10|25|50] records per page
| 國立成功大學 |
2024-06 |
Estimation of natural convection heat transfer characteristics of rack server in a cavity: experimental and numerical analyzes
|
Chen;Han-Taw;Chen;Kuan-Xun;Amani;Mohammad;Rysavy;J;Yan;Wei-Mon |
| 國立成功大學 |
2024-06 |
Evidence of the γ-ray counterpart of nova FM Cir from Fermi-LAT
|
Wang;H, H. H.;Yan;H, D.;Lin;L, C. -C.;Takata;J;Tam;P, -H. T. |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
Recovery of Lithium from Industrial Li-Containing Wastewater Using Fluidized-Bed Homogeneous Granulation Technology
|
Le;Giang, Van;Luu;Anh, The;Tran;Tuan, Huu;Bui;Ngoc, T.;Mofijur;M;Nguyen;Ky, Minh;Bui;Thanh, Xuan;Bahari;M, B.;Vo;Phong, Hoang Nhat;Vu;Thanh, Chi;Chien;Chang, Guo-Ping;Huang;Yao-Hui |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
An inverse method of fundamental solutions for the identification of 2D elastic properties of anisotropic solids
|
Hematiyan;M, R.;Khosravifard;A;Mohammadi;M;Shiah;Y, C. |
| 國立成功大學 |
2024-06 |
Investigating the protective role of CD44 and microRNA-146a in tendinopathic tenocytes: a signaling axis regulating apoptosis
|
Chen;S;Wu;P |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
| 國立成功大學 |
2024-06 |
Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study
|
Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M |
Showing items 836-845 of 4992 (500 Page(s) Totally)
<< < 79 80 81 82 83 84 85 86 87 88 > >>
View [10|25|50] records per page
|
